Measuring the Cardio-metabolic Response to Diet Quality Modification During Night Work: Shift-eat (Night) Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Shift Work
- Sponsor
- King's College London
- Enrollment
- 4
- Locations
- 1
- Primary Endpoint
- Blood glucose variability (mean amplitude of glycaemic excursions)
- Status
- Terminated
- Last Updated
- 3 years ago
Overview
Brief Summary
The aim of this pilot study is to investigate the acute impact of diet quality modification during night work on 24-hr glucose variability (GV) and heart rate variability (HRV) in healthy free-living employees.
Detailed Description
An increasing body of data reports deterioration of cardio-metabolic health in shift workers. For example, large scale meta-analyses have reported shift workers to be at increased risk of developing type 2 diabetes and of experiencing a coronary event, compared to day working employees. Shift work causes complex changes in physiology (desynchrony of circadian rhythms) and behaviors including activity, sleep and eating patterns. The importance of meal timing is becoming increasingly recognized in both chronobiology and nutrition fields, with emerging awareness of 'chrono-nutrition', the interaction between nutrition and circadian time. Given the importance to the economy of a healthy aging workforce, and the increase in shift work prevalence, it is important to establish if diet modification can reduce the health disparities between shift and day working employees.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Current night shift worker (defined as a period of work between 11pm and 6am) working regular blocks of 3 night shifts.
- •Body mass index between 18.5 and 35 kg/m
- •Weight stable (no weight change by more than 3 kg in the last 2 months).
- •Not a regular smoker (1 or more cigarettes per day) and would be willing not to smoke for the duration of the study.
- •Not pregnant or breastfeeding.
- •Not diagnosed with heart attack, stroke, angina, thrombosis, liver or kidney diseases, diabetes, chronic gastrointestinal disorder or cancer.
- •Not currently taking medication to stabilize blood glucose (e.g. acarbose, metformin or sulfonylureas).
- •Not started new medication within the last 3 months likely to interfere with energy metabolism, appetite regulation and hormonal balance, including: anti-inflammatory drugs or steroids, antibiotics, androgens, phenytoin, erythromycin or thyroid hormones.
- •Do not take medication for blood pressure e.g. diuretics, (beta-blockers, Ca-channel, ACE inhibitors, Angiotensin Receptor blockers)
- •Do not have diagnosed hypertension (high blood pressure, systolic blood pressure that is higher than 180 mmHg and or diastolic blood pressure that is higher than 110 mmHg).
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Blood glucose variability (mean amplitude of glycaemic excursions)
Time Frame: 3 night shifts, an average of 72 hours
24-hr blood glucose variability measured by continuous glucose monitor
Blood glucose variability (time in range)
Time Frame: 3 night shifts, an average of 72 hours
24-hr blood glucose variability measured by continuous glucose monitor
Heart rate variability
Time Frame: 3 night shifts, an average of 72 hours
24-hr heart rate variability measured by heart rate monitor
Blood glucose variability (coefficient variation)
Time Frame: 3 night shifts, an average of 72 hours
24-hr blood glucose variability measured by continuous glucose monitor
Secondary Outcomes
- Acceptability of test diet(3 night shifts, an average of 72 hours)